3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Oropharyngeal Neoplasms
2
Breast Neoplasms
2
Adenocarcinoma
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Squamous Cell Cancer of Head and Neck (SCCHN)
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Pelvic Neoplasms
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Meningioma
1
Medulloblastoma
1
Malignant Liver Neoplasm
1
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Radiotherapy, Image-Guided
×
1 year
×
Clear all
No trials found.